Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a shorter, all-oral, precision treatment regimen for rifampicin-resistant tuberculosis in a Chinese cohort; currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Rifampicin-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Rifampicin Resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Status: NOT_YET_RECRUITING